Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension
Top Cited Papers
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 92 (1) , 1-20
- https://doi.org/10.1016/s0163-7258(01)00157-7
Abstract
No abstract availableKeywords
This publication has 155 references indexed in Scilit:
- The Prostacyclin-Mimetic Cicaprost Inhibits Endogenous Endothelin-1 Release From Human Pulmonary Artery Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 2000
- Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: comparative effects on pulmonary vascular structure and functionBritish Journal of Pharmacology, 1999
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertensionLife Sciences, 1996
- Endothelin-Induced Collagen Remodeling in Experimental Pulmonary HypertensionBiochemical and Biophysical Research Communications, 1995
- Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertensionThe Journal of Pediatrics, 1993
- Both membrane stretch and fatty acids directly activate large conductance Ca2+‐activated K+ channels in vascular smooth muscle cellsFEBS Letters, 1992
- Stretch increases inositol trisphosphate and inositol tetrakisphosphate in cultured pulmonary vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1991
- Effect of alveolar pressure on pulmonary artery pressure in chronically hypoxic ratsCardiovascular Research, 1987
- Hypoxic pulmonary vasoconstriction in chronically hypoxic ratsRespiration Physiology, 1984